Free Republic 2nd Qtr 2024 Fundraising Target: $81,000 Receipts & Pledges to-date: $19,829
24%  
Woo hoo!! And we're now over 24%!! Thank you all very much!! God bless.

Keyword: shinyayamanaka

Brevity: Headers | « Text »
  • Embryonic Stem Cells Still Haven’t Performed Miracles

    11/22/2011 7:25:47 PM PST · by raptor22 · 11 replies
    Investor's Business Daily ^ | November 22, 2011 | IBD staff
    Subsidies: A firm that received tax dollars to pursue embryonic stem cell research abandons what was touted as the most promising avenue of research for medical miracles. Then there's that "conscience thing." When Geron Corp. announced in January 2010 that the first clinical trial using its embryonic stem cells to treat an actual human patient was under way, its stock shot up 6.4%. Geron got the first Food and Drug Administration license to use embryonic stem cells to treat people in a clinical trial, in this case patients with a spinal cord injury. Last week Geron announced that it was...
  • Stem Cells: Japan Gets Ahead of the Curve

    11/19/2007 5:25:46 PM PST · by neverdem · 16 replies · 133+ views
    Time ^ | Jun. 14, 2007 | Bryan Walsh
    Everything about Shinya Yamanaka's discovery was right—except for the timing. The 44-year-old Kyoto University stem-cell researcher had found a way to genetically reprogram an ordinary mouse skin cell to revert to the virtual equivalent of its embryonic state, in which it has the potential to grow into any kind of tissue. The finding was a promising first step toward the creation of stem-cell lines for near-miraculous medical treatments—and because Yamanaka did not use human embryos, his technique offered researchers everywhere a way to sidestep the ethical controversies that have dogged the field since its birth. But it was March 2006,...